ArticleWorld journal of urology2024
Is PI‑RADS upgrading the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI‑RADS‑3 lesions?
Elaheh Sanjari et al.PubMed ↗Publisher ↗
No numbers read from the abstract.